Elizabeth Da Silva

Dr. da Silva is a microbiologist with over 20 years of experience in regulatory affairs and drug development. Her experience spans early development through post-approval and lifecycle management, both in the US and ex-US regulatory environments.

As Head of Regulatory Affairs, Dr. da Silva provides overall strategic direction and leadership of Regulatory Affairs activities at Nevakar to deliver high quality regulatory strategies, US and ex-US filings and ensure compliance with FDA regulations and other applicable global regulatory requirements.

Prior to joining Nevakar Injectables, she held roles with increasing responsibility at Daiichi Sankyo, Pfizer and Acorda Therapeutics. Dr. da Silva has led regulatory teams from IND submission through to successful NDA approval in a variety of therapeutic areas.

Dr. da Silva received a BS in Microbiology from the University of Pretoria, South Africa and holds a Masters’ and PhD degrees in Microbiology and Microbial Genetics from the University of Lausanne, Switzerland.